Rhizen Pharmaceuticals Sa

This study tests a new drug called tenalisib in 40 people with metastatic triple negative breast cancer who have already tried 1 to 3 other treatments. The goal is to see if the drug can shrink tumors or stop them from growing for at least 16 weeks. Researchers will also monitor …